E51-COVID-19 and anti-septics, Ocular Tissue Detection, & Ontario Surgical Backlog-Dr. Tina Felfeli

Dr. Tina Felfeli discusses 3 articles around COVID-19 and ophthalmology: (1) Effect of various concretions and exposure times of common ophthalmology anti-septics on COVID-19 infected cell lines. (2) Effect of the pandemic on the backlog of elective ophthalmic surgical cases in the province of Ontario, Canada (3) Detection of the COVID-19 virus in different ocular tissues of a patient that tested positive for COVID-19.  Referenced articles: Felfeli T, Kasloff SB, Krishnan J, El-Defrawy SR, Mazzulli T, Cutts TA. In vitro efficacy of topical ophthalmic antiseptics against SARS-CoV-2. BMJ Open Ophthalmol. 2021 Jun 9;6(1):e000765. doi: 10.1136/bmjophth-2021-000765. PMID: 34192157; PMCID: PMC8190983. Predicting the Ophthalmic Surgical Backlog as a Result of the COVID-19 Pandemic: A population-based study and microsimulation model to inform surgical recovery plans Tina Felfeli, Raphael Ximenes, David MJ Naimark, Philip L Hooper, Robert J Campbell, Sherif R El-Defrawy, Beate Sander, the COVID-19 Mod Collab medRxiv 2021.03.25.21254375; doi:https://doi.org/10.1101/2021.03.25.21254375 Felfeli T, Mazzulli T, Clark ST, El-Defrawy SR, Chan CC. SARS-CoV-2 Not Detectable in Ocular Specimens of a Patient with a Past Infection. Ocul Immunol Inflamm. 2021 Apr 7:1-3. doi: 10.1080/09273948.2021.1894458. Epub ahead of print. PMID: 33826479.